|
THURSDAY, 24 MAY |
|
|
|
|
|
|
Atherosclerosis |
|
|
Rene M. Botnar, Ph.D., and Bruce A. Wasserman, M.D.,
Organizers |
|
|
Skill Level: Intermediate |
|
|
Overview
This two-hour course will provide an overview on
state-of-the-art in-vivo coronary and carotid plaque
visualization and characterization at 1.5 and 3T.
Special emphasis will be given to the use of target
specific contrast agents that are thought to facilitate
detection of vulnerable lesions.
Educational Objectives
Upon
completion of this course, attendees should be able to:
•
describe the use of MRI
to evaluate atherosclerotic disease in the carotid and
coronary arteries;
•
describe new
applications in high field MRI to understand the
pathobiology of atherosclerotic disease; and
•
evaluate the role of
novel contrast agents and their contribution to
understanding the structure and detection of
atherosclerosis.
Audience
Description
The
clinical categorical courses are designed for clinical
radiologists, neuroradiologists, neurosurgeons,
neurologists, cardiologists,
oncologists, practicing clinicians and scientists, from
beginning to advanced experience levels working in MR. |
|
|
10:30 |
MRI of Coronary Atherosclerosis |
David Maintz, M.D. |
|
10:50 |
MRI of Carotid Atherosclerosis |
Bruce A. Wasserman |
|
11:10 |
Atherosclerosis imaging at high field strength |
Chun Yuan, Ph.D. |
|
|
Contrast agent imaging: |
|
|
11:30 |
Non targeted contrast agents |
Matthias Taupitz, M.D. |
|
11:50 |
Iron-labeled nanoparticles |
David Sosnovik, M.D. |
|
12:10 |
Gd-labeled nanoparticles |
Samuel A. Wickline, M.D. |
|
12:30 |
Adjournment |
|
|
|
|
|
|
|
|
|
|